Stage III Pancreatic Cancer
Showing 1 - 25 of 61
Colorectal Adenocarcinoma, Gastric Adenocarcinoma, Metastatic Pancreatic Adenocarcinoma Trial in Atlanta (Nanoliposomal
Recruiting
- Colorectal Adenocarcinoma
- +13 more
- Nanoliposomal Irinotecan
- Trifluridine and Tipiracil Hydrochloride
-
Atlanta, Georgia
- +2 more
Jan 6, 2023
Metastatic Pancreatic Carcinoma, Stage II Pancreatic Cancer, Stage IIA Pancreatic Cancer Trial in Salt Lake City
Recruiting
- Metastatic Pancreatic Carcinoma
- +6 more
-
Salt Lake City, UtahHuntsman Cancer Institute/University of Utah
Oct 31, 2022
Head and Neck Squamous Cell Carcinoma, Metastatic Pancreatic Adenocarcinoma, Non-Resectable Cholangiocarcinoma Trial in Los
Active, not recruiting
- Head and Neck Squamous Cell Carcinoma
- +15 more
- Cisplatin
- +6 more
-
Los Angeles, California
- +1 more
Aug 5, 2022
Adenocarcinoma of the Pancreas, Stage III Pancreatic Cancer, Stage IV Pancreatic Cancer Trial in Buffalo (dovitinib lactate,
Completed
- Adenocarcinoma of the Pancreas
- +3 more
- dovitinib lactate
- +5 more
-
Buffalo, New YorkRoswell Park Cancer Institute
Jul 20, 2022
Colorectal Adenocarcinoma, Metastatic Pancreatic Adenocarcinoma, Recurrent Colorectal Carcinoma Trial in Atlanta (XL888,
Active, not recruiting
- Colorectal Adenocarcinoma
- +14 more
- XL888
- Pembrolizumab
-
Atlanta, Georgia
- +2 more
Jul 5, 2022
Metastatic Pancreatic Adenocarcinoma, Recurrent Pancreatic Carcinoma, Stage III Pancreatic Cancer Trial in Detroit (biological,
Completed
- Metastatic Pancreatic Adenocarcinoma
- +3 more
- Aldesleukin
- +9 more
-
Detroit, MichiganWayne State University/Karmanos Cancer Institute
Mar 30, 2022
Solid Tumor, Stage III Pancreatic Cancer, Stage IIIA Breast Cancer Trial in Atlanta (Carboplatin, Cisplatin, Palbociclib)
Active, not recruiting
- Solid Neoplasm
- +16 more
- Carboplatin
- +2 more
-
Atlanta, GeorgiaEmory University/Winship Cancer Institute
Feb 28, 2022
Acute Myeloid Leukemia, Brain Glioblastoma, Estrogen Receptor Negative Trial in Fullerton (Best Practice, Laboratory Biomarker
Active, not recruiting
- Acute Myeloid Leukemia
- +66 more
- Best Practice
- +3 more
-
Fullerton, CaliforniaVirginia K Crosson Cancer Center
Jan 31, 2022
Colon Carcinoma Metastatic in the Liver, Colorectal Adenocarcinoma, Pancreatic Adenocarcinoma Trial in Atlanta, Rochester
Active, not recruiting
- Colon Carcinoma Metastatic in the Liver
- +13 more
- Anti-SEMA4D Monoclonal Antibody VX15/2503
- +3 more
-
Atlanta, Georgia
- +3 more
Dec 15, 2021
Pancreatic Adenocarcinoma, Stage IA Pancreatic Cancer, Stage IB Pancreatic Cancer Trial in Richmond (drug, radiation, other)
Active, not recruiting
- Pancreatic Adenocarcinoma
- +6 more
- Gemcitabine
- +6 more
-
Richmond, VirginiaVirginia Commonwealth University/Massey Cancer Center
Oct 20, 2021
Acinar Cell Adenocarcinoma of the Pancreas, Duct Cell Adenocarcinoma of the Pancreas, Recurrent Pancreatic Cancer Trial in Bronx
Completed
- Acinar Cell Adenocarcinoma of the Pancreas
- +4 more
- paclitaxel
- bryostatin 1
-
Bronx, New YorkMontefiore Medical Center
May 18, 2021
Gastrinoma, Glucagonoma, Insulinoma Trial in Stanford (Capecitabine, Temozolomide, Bevacizumab)
Completed
- Gastrinoma
- +8 more
- Capecitabine
- +2 more
-
Stanford, CaliforniaStanford University Medical Center
Apr 8, 2021
Stage I Adult Liver Cancer, Stage I Colorectal Cancer, Stage IA Gastric Cancer Trial in Duarte (Computer-Assisted Intervention,
Completed
- Stage I Adult Liver Cancer
- +30 more
- Computer-Assisted Intervention
- +3 more
-
Duarte, CaliforniaCity of Hope Medical Center
Jan 5, 2021
Adenocarcinoma of the Pancreas, Stage II Pancreatic Cancer, Stage III Pancreatic Cancer Trial in Philadelphia (drug, radiation,
Completed
- Adenocarcinoma of the Pancreas
- +2 more
- capecitabine
- +4 more
-
Philadelphia, PennsylvaniaRadiation Therapy Oncology Group
Oct 29, 2020
Adenocarcinoma of the Pancreas, Stage II Pancreatic Cancer, Stage III Pancreatic Cancer Trial in Philadelphia (gemcitabine HCl,
Completed
- Adenocarcinoma of the Pancreas
- +2 more
- gemcitabine hydrochloride
- +3 more
-
Philadelphia, PennsylvaniaRadiation Therapy Oncology Group
Oct 29, 2020
Adenocarcinoma of the Pancreas, Recurrent Pancreatic Cancer, Stage III Pancreatic Cancer Trial in San Francisco, Columbus
Completed
- Adenocarcinoma of the Pancreas
- +3 more
- erlotinib hydrochloride
- +2 more
-
San Francisco, California
- +1 more
Jul 29, 2020
Acinar Cell Adenocarcinoma of the Pancreas, Adenocarcinoma of the Gallbladder, Adenocarcinoma of Unknown Primary Trial in
Completed
- Acinar Cell Adenocarcinoma of the Pancreas
- +39 more
- oxaliplatin
- +4 more
-
Chicago, Illinois
- +1 more
May 7, 2020
Duct Cell Adenocarcinoma of the Pancreas, Recurrent Pancreatic Cancer, Stage III Pancreatic Cancer Trial in Chicago (biological,
Completed
- Duct Cell Adenocarcinoma of the Pancreas
- +3 more
- ipilimumab
- +2 more
-
Chicago, IllinoisNorthwestern University
Feb 24, 2020
Pancreatic Adenocarcinoma, Resectable Pancreatic Carcinoma, Stage I Pancreatic Cancer Trial in Omaha (procedure, drug, other,
Completed
- Pancreatic Adenocarcinoma
- +8 more
- 4-Dimensional Computed Tomography
- +8 more
-
Omaha, NebraskaUniversity of Nebraska Medical Center
Feb 24, 2020
Pancreatic Adenocarcinoma, Recurrent Pancreatic Carcinoma, Stage III Pancreatic Cancer Trial in Philadelphia (Oxaliplatin,
Completed
- Pancreatic Adenocarcinoma
- +4 more
- Oxaliplatin
- +4 more
-
Philadelphia, PennsylvaniaSidney Kimmel Cancer Center at Thomas Jefferson University
Jan 15, 2020
Adenocarcinoma of the Pancreas, Stage III Pancreatic Cancer Trial in Omaha (drug, radiation, procedure)
Completed
- Adenocarcinoma of the Pancreas
- Stage III Pancreatic Cancer
- gemcitabine hydrochloride
- +6 more
-
Omaha, NebraskaUniversity of Nebraska Medical Center
Aug 9, 2019
Acinar Cell Adenocarcinoma of the Pancreas, Duct Cell Adenocarcinoma of the Pancreas, Stage IIB Pancreatic Cancer Trial in
Terminated
- Acinar Cell Adenocarcinoma of the Pancreas
- +3 more
- gemcitabine hydrochloride
- +4 more
-
Philadelphia, PennsylvaniaFox Chase Cancer Center
Jul 26, 2019
Acinar Cell Adenocarcinoma of the Pancreas, Duct Cell Adenocarcinoma of the Pancreas, Recurrent Pancreatic Cancer Trial in
Completed
- Acinar Cell Adenocarcinoma of the Pancreas
- +4 more
- 6,8-bis(benzylthio)octanoic acid
-
Winston-Salem, North CarolinaComprehensive Cancer Center of Wake Forest University
Dec 26, 2018
Acinar Cell Adenocarcinoma of the Pancreas, Duct Cell Adenocarcinoma of the Pancreas, Stage III Pancreatic Cancer Trial in
Completed
- Acinar Cell Adenocarcinoma of the Pancreas
- +2 more
- porfimer sodium
- +3 more
-
Indianapolis, IndianaIU Simon Cancer Center
Dec 11, 2018